xuebijing

Botanicalexperimental

Clinical trial activity

5 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2

Earliest trial started Oct 1, 2016 (NCT02937974)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • xuebijing

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07026227N/AFeb 20, 2023Hebei University
NCT04993794N/AJan 1, 2021Nanjing Medical University
NCT03475732N/AMar 18, 2018Chinese Academy of Medical Sciences, Southeast University
NCT03238742Phase 4Oct 1, 2017National Health and Family Planning Commission, P.R.China, Southeast University, Tianjin Chase Sun Pharmaceutical Co., LTD
NCT02937974Phase 4Oct 1, 2016Capital Medical University, People's Liberation Army of China
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Southeast UniversityAcademic/Hospital2222017
Capital Medical UniversityAcademic/Hospital1012016
Chinese Academy of Medical SciencesAcademic/Hospital1012018
Hebei UniversityAcademic/Hospital1112023
Nanjing Medical UniversityAcademic/Hospital1112021
National Health and Family Planning Commission, P.R.ChinaGovernment1012017
People's Liberation Army of ChinaGovernment1112016
Tianjin Chase Sun Pharmaceutical Co., LTDFor profit1012017
8 organizations
Page 1 / 1